EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?
- PMID: 37740525
- PMCID: PMC10885813
- DOI: 10.1111/apa.16977
EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?
Comment on
-
Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2023 May 1;6(5):e2315315. doi: 10.1001/jamanetworkopen.2023.15315. JAMA Netw Open. 2023. PMID: 37256621 Free PMC article. Clinical Trial.
References
-
- Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: Effect modification by risk of bronchopulmonary dysplasia. Journal of Pediatrics 2014; 165. doi:10.1016/j.jpeds.2014.07.049. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources